Being able to replicate scientific findings is crucial for scientific progress [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] . We replicate 21 systematically selected experimental studies in the social sciences published in Nature and Science between 2010 and 2015 . The replications follow analysis plans reviewed by the original authors and pre-registered prior to the replications. The replications are high powered, with sample sizes on average about five times higher than in the original studies. We find a significant effect in the same direction as the original study for 13 (62%) studies, and the effect size of the replications is on average about 50% of the original effect size. Replicability varies between 12 (57%) and 14 (67%) studies for complementary replicability indicators. Consistent with these results, the estimated truepositive rate is 67% in a Bayesian analysis. The relative effect size of true positives is estimated to be 71%, suggesting that both false positives and inflated effect sizes of true positives contribute to imperfect reproducibility. Furthermore, we find that peer beliefs of replicability are strongly related to replicability, suggesting that the research community could predict which results would replicate and that failures to replicate were not the result of chance alone.
Being able to replicate scientific findings is crucial for scientific progress [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] . We replicate 21 systematically selected experimental studies in the social sciences published in Nature and Science between 2010 and 2015 . The replications follow analysis plans reviewed by the original authors and pre-registered prior to the replications. The replications are high powered, with sample sizes on average about five times higher than in the original studies. We find a significant effect in the same direction as the original study for 13 (62%) studies, and the effect size of the replications is on average about 50% of the original effect size. Replicability varies between 12 (57%) and 14 (67%) studies for complementary replicability indicators. Consistent with these results, the estimated truepositive rate is 67% in a Bayesian analysis. The relative effect size of true positives is estimated to be 71%, suggesting that both false positives and inflated effect sizes of true positives contribute to imperfect reproducibility. Furthermore, we find that peer beliefs of replicability are strongly related to replicability, suggesting that the research community could predict which results would replicate and that failures to replicate were not the result of chance alone.
To what extent can we trust scientific findings? The answer to this question is of fundamental importance [1] [2] [3] , and the reproducibility of published studies has been questioned in many fields [4] [5] [6] [7] [8] [9] [10] . Until recently, systematic evidence has been scarce [11] [12] [13] [14] [15] . The Reproducibility Project: Psychology (RPP) 12 put the question of scientific reproducibility at the forefront of scientific debate [37] [38] [39] . The RPP replicated 100 original studies in psychology and found a significant effect in the same direction as the original studies for 36% of the 97 studies reporting 'positive findings' 12 . The RPP was followed by the Experimental Economics Replication Project (EERP), which replicated 18 laboratory experiments in economics and found a significant effect in the same direction as the original studies for 61% of replications 13 . Both the RPP and the EERP had high statistical power to detect the effect sizes observed in the original studies. However, the effect sizes of published studies may be inflated even for true-positive findings owing to publication or reporting biases [40] [41] [42] . As a consequence, if replications were well powered to detect effect sizes smaller than those observed in the original studies, replication rates might be higher than those estimated in the RPP and the EERP.
We provide evidence about the replicability of experimental studies in the social sciences published in the two most prestigious general science journals, Nature and Science (the Social Sciences Replication Project (SSRP)). Articles published in these journals are considered exciting, innovative and important. We include all experimental studies published between 2010 and 2015 that (1) test for an experimental treatment effect between or within subjects, (2) test at least one clear hypothesis with a statistically significant finding, and (3) were performed on students or other accessible subject pools. Twenty-one studies were identified to meet these criteria. We used the following three criteria in descending order to determine which treatment effect to replicate within each of these 21 papers: (a) select the first study reporting a significant treatment effect for papers reporting more than one study, (b) from that study, select the statistically significant result identified in the original study as the most important result among all within-and between-subject treatment comparisons, and (c) if there was more than one equally central result, randomly select one of them for replication. The interpretation of which was the most central and important statistically significant result within a study in criteria (b) above was made by us and not by the original authors. See Supplementary Methods and Supplementary Tables 1  and 2 for details.
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To address the possibility of inflated effect sizes in the original studies, we used a high-powered design and a two-stage procedure for conducting the replications. In stage 1, we had 90% power to detect 75% of the original effect size at the 5% significance level in a two-sided test. If the original result replicated in stage 1 (a two-sided P < 0.05 and an effect in the same direction as in the original study), no further data collection was carried out. If the original result did not replicate in stage 1, we carried out a second data collection in stage 2 to have 90% power to detect 50% of the original effect size for the first and second data collections pooled.
The motivation for having 90% power to detect 50% of the original effect size was based on the replication effect sizes in the RPP being on average about 50% of the original effect sizes 12 (see Supplementary Methods for details; the average relative effect size of the replications in the EERP was 66% 13 ). On average, replication sample sizes in stage 1 were about three times as large as the original sample sizes and replication sample sizes in stage 2 were about six times as large as the original sample sizes. All of the replication and analysis plans were made publicly known on the project website, pre-registered at the Open Science Framework (OSF) and sent to the original authors for feedback and verification prior to data collection (the pre-replication versions of the replication reports and the final versions are posted at the project's OSF repository (https://osf.io/pfdyw/); the final versions of the replication reports include a section called 'Unplanned protocol deviations' , which lists any deviations from the pre-registered replication protocols and these deviations are also listed towards the end of the Supplementary Methods. There was no deviation from the protocol for 7 replications 17, 18, [20] [21] [22] 25, 35 , minor deviations for 12 replications 19, 23, 24, 26, 27, [29] [30] [31] [32] [33] [34] 36 , an unintended methodological deviation for one replication 28 , and a continuation to the stage 2 data collection by mistake for one replication 16 . There is no universally agreed on criterion for replication 12, [43] [44] [45] [46] , but our power analysis strategy is based on detecting a significant effect in the same direction as the original study using the same statistical test. As such, we treat this as the primary indicator of replication and refer to it as the statistical significance criterion. This approach is appealing for its simplicity as a binary measure of replication, but does not fully represent evidence of reproducibility. We also provide results for the relative effect size of the replication as a continuous measure of the degree of replication. To complement these indicators, we present results for: (1) 20, 31 replicate based on this criterion. By mistake, a second data collection was carried out for one study 16 replicating in stage 1; thus, we also include this study in the stage 2 results to base our results on all the data collected. This study 16 does not replicate in stage 2. This may suggest that replication studies should routinely be powered to detect at least 50% of the original effect size or that one should use a lower P value threshold than 0.05 for not continuing to stage 2 in our two-stage testing procedure. Based on all of the data collected, 13 (61.9%) studies replicated after stage 2 using the statistical significance criterion.
The mean standardized effect size (correlation coefficient r) of the replications is 0.249, compared to 0.460 in the original studies ( Supplementary Fig. 4 ). This difference is significant (Wilcoxon signed-ranks test, z = 3.667, P < 0.001, n = 21) and the mean relative effect size of the replications is 46.2%. For the 13 studies that replicated, the mean relative effect size is 74.5%, and for the 8 studies that did not replicate, the mean relative effect size is 0.3%. It is not surprising that the mean relative effect size is smaller for the non-replicating effects than for the replicating effects as these are correlated indicators. However, it is notable that, even among the replicating effects, the effect sizes for the replications were weaker than the original findings, and for the non-replicating effects, the mean effect sizes were approximately zero.
We also combined the original result and the replication in a meta-analytic estimate of the effect size. As seen in Fig. 1c, 16 studies (76.2%) have a significant effect in the same direction as the original study in the meta-analysis. However, the meta-analysis assumes that the results of the original studies are not influenced by publication or reporting biases, making the meta-analytic results an overly optimistic indicator compared to criteria that focused on the replication evidence 12 . A team recently suggested that the P value threshold for significant findings should be lowered from 0.05 to 0.005 for new discoveries 51 . In a replication context, it would be relevant to apply this stricter threshold to meta-analytic results. In this case, the meta-analysis leads to the same conclusions about replication as our primary replication indicator (that is, 13 studies or 61.9% of studies have a P < 0.005 in the meta-analysis). It is obvious that the 13 successful replications would achieve P < 0.005 when the original and replication results were pooled, but this criterion could have also included replications that did not achieve P < 0.05 but were in the right direction and were combined with an original study with particularly strong evidence.
A complementary replication criterion is to count how many replicated effects lie in a 95% prediction interval 47 , which takes into account the variability in both the original study and the replication study. Using this method, 14 effects replicated (66.7%; see Fig. 2a and Supplementary Methods for details). This method yields the same replication outcome as the statistical significance criterion for 20 of the 21 studies.
The small telescopes approach estimates whether the replication effect size is significantly smaller than a 'small effect' in the original study with a one-sided test at the 5% level. A small effect is defined as the effect size that the original study would have had 33% power to detect. Following the small telescopes approach 46 , 12 studies (57.1%) replicate (see Fig. 2b and Supplementary Methods for details). One replication has a significant effect in the same direction as the original study, but the effect size is significantly smaller than a small effect as defined by the small telescopes approach. This is the only difference compared to the statistical significance criterion.
Another way to represent the strength of evidence in favour of the original result versus the null hypothesis of no effect is to estimate the Bayes factor 45, 48, 52, 53 . The Bayes factor compares the predictive performance of the null hypothesis against that of an alternative hypothesis in which the uncertainty about the true effect size is quantified by a prior distribution. The prior distributions were first set to their generic defaults; they were then folded across the test value so that all prior mass was consistent with the direction of the effect from the original study, thereby implementing a Bayesian one-sided test (see the Supplementary Methods for details). For example, the replication of Pyc and Rawson 31 yielded a one-sided default Bayes factor of BF +0 = 6.8, meaning that the one-sided alternative hypothesis out predicted the null hypothesis of no effect by a factor of almost 7.
The one-sided default Bayes factor exceeds 1, providing evidence in favour of an effect in the direction of the original study for the 13 (61.9%) studies that replicated according to our primary replication indicator (Fig. 3 ). This evidence is strong to extreme for 9 (42.9%) studies. The default Bayes factor is below 1 for 8 (38.1%) studies, providing evidence in support of the null hypothesis; this evidence is strong to extreme for 4 (19.0%) studies.
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In additional Bayesian analyses, we use an errors-in-variables mixture model 49 to estimate the true-positive rate in the total sample (see the Supplementary Methods and Supplementary Fig. 5 for details). The estimated true-positive rate is 67% ( Supplementary  Fig. 5 ), which is close to the other replicability estimates. The mixture model also estimates that the average relative effect size of true positives is 71% ( Supplementary Fig. 5 ), suggesting that the original studies overestimated the effect sizes of true positives.
We also estimate peer beliefs about replicability using surveys and prediction markets 50, 54 (see Supplementary Methods, Supplementary Table 5 and Supplementary Fig. 6 for details). The prediction markets produce a collective peer estimate of the probability of replication that can be interpreted as a reproducibility indicator 50 . The average prediction market belief of replicating after stage 2 is a replication rate of 63.4% and the average survey belief is 60.6%, which are both close to the observed replication rate of 61.9% ( Tables 5 and 6 for more details). The prediction market beliefs and the survey beliefs are highly correlated and both are highly correlated with a successful replication ( Fig. 4 and Supplementary Fig. 7) ; that is, in the aggregate, peers were very effective at predicting future replication success.
In the RPP 12 and the EERP 13 , replication success was negatively correlated with the P value of the original study, suggesting that original study P values might be a predictor of replicability. We also find a negative correlation between the P value of the original study and replication success, although it is not significant (Spearman correlation coefficient: -0.405, P = 0.069, 95% CI = − 0.712 to 0.033, n = 21); the estimate is in between the correlations found in the RPP (-0.327) and the EERP (-0.572) (Supplementary Table 7 ). That peers are to some extent able to predict which studies are most likely to replicate suggests that there are features of the original studies that journals or researchers can use in determining ex ante whether a study is likely to replicate. Taken together, the results from the RPP, EERP and SSRP suggest that the P value of the original study is one such important determinant of replication. The SSRP with n = 21 studies is too small to reliably test determinants of replications, but pooling the results of all large-scale replication projects may offer a higher-powered opportunity to explore moderators of replication.
To summarize, we successfully replicated 13 out of 21 findings from experimental social and behavioural science studies published in Science or Nature between 2010 and 2015 based on the statistical significance criterion with very high-powered studies compared to the RPP 12 and the EERP 13 . This number is larger than the replication rate of the RPP and similar to the replication rate of the EERP (Supplementary Fig. 9 ). However, the small sample of studies and different selection criteria make it difficult to draw any interpretation confidently in comparison with those studies. However, we can conclude that increasing power substantially is not sufficient to reproduce all published studies. Furthermore, we observe that the conclusions across binary replication criteria converge with increased statistical power. The small telescopes and the 95% prediction interval indicators drew different conclusions on only one of the replications compared to the statistical significance criterion. , minor deviations for 12 replications 19, 23, 24, 26, 27, [29] [30] [31] [32] [33] [34] 36 , an unintended methodological deviation for one replication 28 and a continuation to the stage 2 data collection by mistake for one replication 16 .
Considering statistical significance and effect sizes simultaneously, we observe two major outcomes. First, even among successful replications, the estimated effect sizes were smaller than the original study. For the 13 studies that replicated according to the statistical significance criterion, the replication effect sizes were about 75% of the original effect size. This provides an estimate of the overestimation of effect sizes of true positives in the original studies. The Bayesian mixture model corroborates this result, yielding an estimate of the relative effect size of true positives of 71%. This implies that meta-analyses of true-positive findings will overestimate effect sizes on average. This finding bolsters evidence that the existing literature contains exaggerated effect sizes because of pervasive low-powered research coupled with bias selecting for significant results for publication 8, 12 . In addition, if this finding generalizes to the literatures investigated by the RPP and the EERP, it suggests that the statistical power of these two projects, in which the sample sizes were determined to obtain 90% power to detect the original effect size, was de-facto smaller than intended. This would imply that the replication rates, based on the statistical significance criterion, were underestimated in these studies, consistent with those authors' speculation.
Second, among the unsuccessful replications, there was essentially no evidence for the original finding. The average relative effect size was very close to zero for the eight findings that failed to replicate according to the statistical significance criterion. The expected relative effect size for a sample of false positives is zero, but this observation does not demand the conclusion that the eight original findings were false positives. Another possibility is that the replication studies failed to implement necessary features of the protocol to detect the effect 38 . We cannot rule out this alternative, but we also do not have evidence for necessary features missing from the replications that would reduce the observed effect sizes to zero. Indeed, it would be surprising but interesting to identify an unintended difference that completely eliminated the effect rather than just reduce the effect size. One suggested indicator for whether differences between studies are a likely cause for bias is the endorsement of the original authors 38 . In the current project, we took extensive efforts to ensure that the replications would be as close as possible to the originals. All of the replications but one 35 were designed with the collaboration of the original authors (for the replication 35 that was not designed with the collaboration of the original authors, the original authors did not respond to our queries). Furthermore, all of the reviewed replications but one 32 were approved by the original authors. However, none of this implies that the original authors agree with the final outcomes or interpretation. For example, changes in planned implementation or insights after observing the results could lead to different interpretations of the replication outcome and ideas for subsequent research to clarify the understanding of the phenomenon. See the Supplementary Methods and the posted replication reports for each study for more details, including follow-up comments from the original authors if provided. Another hypothesis that could account for replication failures, at least partly, is the result of chance, such as a large degree of heterogeneity in treatment effects in different samples 38 . However, such 46 (the effect size that the original study would have had 33% power to detect). Effect sizes are standardized to correlation coefficients r and normalized so that 1 equals the original effect size. A study is defined as failing to replicate if the 90% CI is below the small effect. According to the small telescopes approach, 12 out of 21 (57.1%; 95% CI = 34.1-80.2%) studies replicate.
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NaTuRe HumaN BeHaviouR heterogeneity would not affect the average relative effect size of replications, as replications would be as likely to overestimate as underestimate the original effect sizes. Thus, it cannot explain why the average effect sizes of our replications is only about 50% of the original effect sizes. Furthermore, the strong correlation between the peer predictions and the observed replicability is discordant with the possibility that replication failures occurred by chance alone. That is, researchers seem to have identified a priori systematic differences between the studies that replicated and those that did not. This capacity to predict the replicability of effects is a reason for optimism that methods will emerge to anticipate reproducibility challenges and guide efficient use of replication resources towards exciting but uncertain findings.
Below, we discuss some limitations of the SSRP. The SSRP is a small sample of studies with specific selection criteria for experimental studies from two high-profile journals. Work that is published in Nature and Science may be atypical to the field as a whole and may have a stronger focus on novelty, which may also lead to greater-or lesser-editorial scrutiny. The small sample and selective criteria significantly reduce confidence in generalizing these findings to the social science literature more generally. Indeed, like all other research, replications require an accumulation of evidence across multiple efforts to identify and address sampling biases and to obtain increasingly precise estimates of replicability. This study adds to this accumulating literature with a focused, high-powered investigation of high-profile studies published in Nature and Science. Notably, with replication sample sizes about five times larger as the original studies, we get relatively precise estimates of the individual effects of these single replications and the average relative effect sizes that are very similar to what was observed in RPP.
Another important limitation is that, for papers reporting a series of studies, we only replicate one of those studies, and for studies testing more than one hypothesis, we only replicate one hypothesis. Like previous large-scale replication projects, this study does not provide definitive insight on any of the original papers from which we designed the replication studies. An alternative methodology would be to replicate all results within the selected study or all results within all studies in a paper reporting a series of studies. This would give more information from each replication and a more precise estimate of reproducibility of each study and paper. All investigations involve trade-offs. The advantage of an in-depth examination of a hypothesis within a study is greater insight and precision of the reproducibility of its findings. The disadvantage is that many fewer findings can be investigated to learn about the reproducibility of findings more generally. Some other findings reported in the original papers can be tested with the data available in the replications of our study. We did not consider those secondary findings in this paper or in deciding the statistical power plans for the design. However, all of our data and materials are publicly posted on OSF and will be available to other researchers who may want to pursue this issue further in follow-up work.
The original authors in reviewing our paper and replication results have noted some limitations on the replications of their individual studies. These are discussed more in the Supplementary Information; several of the original authors have also posted comments on the replications at the OSF alongside our replication reports. For example, previously unidentified or inadvertent changes to the protocol may have affected replication success for some studies. For more information, see also the Correspondences by the original authors published alongside this Letter. In addition, 
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Fig. 3 | Default Bayes factors (one sided) for the 21 replications.
A default Bayes factor 48 above 1 favours the hypothesis of an effect in the direction of the original paper and a default Bayes factor below 1 favours the null hypothesis (H 0 ) of no effect. The evidence categories proposed by Jeffreys 52 are also shown (from extreme support for the null hypothesis to extreme support for the original hypothesis). The default Bayes factor is above 1 and provides evidence in favour of an effect in the direction of the original study for the 13 out of 21 (61.9%) studies that replicated according to the statistical significance criterion. This evidence is strong to extreme for 9 out of 21 (42.9%) studies. The default Bayes factor is below 1 for 8 out of 21 (38.1%) studies, providing evidence in support of the null hypothesis; this evidence is strong to extreme for 4 out of 21 (19.0%) studies. Values more extreme than 1/300 or 300 are represented on the dashed lines. H 1 , alternative hypothesis.
for papers reporting a series of studies, we replicated the first study that reported a significant treatment effect. In some cases, the original authors argue that other studies in their papers report more important results or use stronger research designs 26, 34 (see the Correspondence by Kidd and Castano, and the Correspondence by Shah et al.) . If the replicability of the first study systematically differs from the replicability of subsequent studies in a paper, our criteria for deciding which study to replicate will systematically overestimate or underestimate replicability.
Inspired by our replication, the original authors of Shah et al. 34 decided to carry out a replication study of their own on all five of their studies (with results posted at https:osf.io/vzm23/).
They did replicate what they consider to be their most important finding: scarcity itself leads to overborrowing. They also failed to replicate study 1 in their paper, consistent with our findings. Their approach of conducting replications of their own studies is admirable and provides additional insight and precision for understanding those effects. Five of our replications were carried out on Amazon Mechanical Turk (AMT), and for one of those (Rand et al. 33 ), the original authors argue that increasing familiarity with economic game paradigms among AMT samples may have decreased the replicability of their result (see the Correspondence by Rand). It cannot be ruled out that changes in the AMT subject pool over time have affected our results, but we also note that the two other studies based on economic game paradigms and AMT data replicated successfully 23, 50 . It would be interesting in future work to test whether replicability differs for older versus newer studies or depends on the time that has elapsed between the original study and the replication.
For the Sparrow et al. 35 replication, the original authors did not provide us with any materials for the replication or feedback on our inquiries. This made it more difficult to replicate the experimental design of the original study. After the replication had been completed, the original authors noted some design differences compared to the original study (see the Correspondence by Sparrow). These design differences are discussed further in the Supplementary Information and we cannot rule out that they influenced the replication result. This illustrates the importance of open access to all of the materials of published studies for conducting direct replications and accumulating scientific knowledge.
The observed replication rate of 62%, based on the statistical significance criterion, adds to a growing pool of replicability rates from various systematic replication efforts with distinct selection and design criteria: the RPP 12 (36%, n = 100 studies), the EERP 13 (61%, n = 18 studies), Many Labs 1 11 (77%; n = 13 studies), Many Labs 2 15 (50%, n = 28 studies) and Many Labs 3 14 (30%, n = 10 studies). It is too early to draw a specific conclusion about the reproducibility rates of experimental studies in the social and behavioural sciences. Each investigation has a relatively small sample of studies with idiosyncratic inclusion criteria and unknown generalizability. However, the diversity in approaches provides some confidence that considering them in the aggregate may provide more general insight about reproducibility in the social behavioural sciences. As a descriptive and speculative interpretation of these findings in the aggregate, we believe that reasonable lower-bound and upper-bound estimates are 35% and 75%, respectively, for an average reproducibility rate of published findings in social and behavioural sciences. Accumulating additional evidence will reveal whether there are systematic biases in these reproducibility estimates themselves. When assessing reproducibility, we are interested in both the systematic bias in the estimated effect sizes of the original studies and the fraction of original hypotheses that are directionally true. The average relative effect size of 50% in the SSRP is a direct estimate of the systematic bias in the published findings of the 21 studies, as it should be 100% if the original studies provide unbiased estimates of true-effect sizes. This estimate assumes that there is no systematic difference in the effectiveness of implementing the study procedures or the appropriateness of testing circumstances between the original and the replication studies. If both of those assumptions are true, then our data indicate that the systematic bias is partly due to false positives and partly due to the overestimated effect sizes of true positives. These systematic biases can be reduced by implementing pre-registration of analysis plans to reduce the likelihood of false positives and registration and reporting of all study results to reduce the effects of publication bias inflating effect sizes 55 . With notable progress on these practices, particularly in the social and behavioural sciences 56 , we predict that replicability will improve over time.
Methods
The methods of the study are detailed in the Supplementary Methods. The replications and the prediction market study were approved by the institutional review board or an ethical review board, and participants gave informed consent to participate. The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement An indication of whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one-or two-sided
Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistics including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted 
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Data collection
We replicated 21 original studies using the software of the original study whenever possible; in the replications where we used other software this is stated in the SI and the Replication Report for each replication (the Replication Reports and all the softwares used in the replications are available at OSF at https://osf.io/pfdyw/).
Data analysis
We have posted code for all data analyses carried out in the Replication Reports for each replication and for all the analyses in the manuscript and SI at OSF (https://osf.io/pfdyw/).
For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information. Policy information about availability of data All manuscripts must include a data availability statement. This statement should provide the following information, where applicable:
-Accession codes, unique identifiers, or web links for publicly available datasets -A list of figures that have associated raw data -A description of any restrictions on data availability
All data for the 21 replications have been posted at OSF (https://osf.io/pfdyw/).
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Study design
All studies must disclose on these points even when the disclosure is negative.
Study description
Replications of 21 experimental studies in the social sciences (with pre-registration of all the replications).
Research sample
The research samples are similar to the ones used in the original studies (students or other easily accessible adult subject pools in line with our inclusion criteria for studies to replicate) and are described in the Replication Reports for each replication posted at OSF (https://osf.io/pfdyw/).
Sampling strategy
The sampling strategy is similar to the one used in the original studies (students or other easily accessible adult subject pools) and are described in the Replication Reports for each replication posted at OSF (https://osf.io/pfdyw/). For sample sizes we used a two-stage procedure with 90% power to detect 75% of the original effect size at the 5% level (two-sided test) in Stage 1; if the effect was not significant in the original direction in Stage 1 a second data-collection was carried out with 90% power to detect 50% of the original effect size at the 5% level (two-sided test) in the pooled first and second stage data collection.
Data collection
The data collection for all replications was done as similarly as possible to the data collection in the original studies and are described in detail in the Replication Report for each replication posted at OSF (https://osf.io/pfdyw/).
Timing
The data collections for the replications were done between September 2016 and September 2017, and the data collection for the prediction markets were done in November 2016.
Data exclusions
We used the same criteria for data exclusions as in the original studies and any deviations from this are stated in the Replication Reports for each replication posted at OSF (https://osf.io/pfdyw/).
Non-participation
Any non-participation is detailed in the Replication Reports for each replication posted at OSF (https://osf.io/pfdyw/).
Randomization
The experimental procedures, including the randomization, follow the original studies and are detailed in the Replication Reports for each replication posted at OSF (https://osf.io/pfdyw/).
